InvestorsHub Logo
Followers 8
Posts 357
Boards Moderated 0
Alias Born 07/30/2015

Re: Closewatcher post# 2658

Monday, 08/07/2017 11:51:59 AM

Monday, August 07, 2017 11:51:59 AM

Post# of 6315
Not surprising. The success of their IPO was almost entirely CEO driven. The indications they've targeted are very risky. The Nemus group expected this and these results is one of the reasons why I maintain Nemus has the most valuable IP and have chosen indications with the best likelihood of success.

Zyne got as high as $40 when it first came out. SMH.